Table 2.
Vaccine strategies in animal models targeting C. difficile surface components.
Antigen | Adjuvant | Route of administration | Schedule | Model | Outcome | Reference |
---|---|---|---|---|---|---|
Spore proteins CdeC, CdeM | Alum | Intraperitoneal | Days 0, 14, 28 | Mouse and hamster | Hundred percent protection in mice. Eighty percent of protection in hamsters | Ghose et al., 2016a |
Cell wall extract | Cholera toxin | Rectal | Days 0, 15, 30 | Hamster | Partial protection against lethal challenge | Péchiné et al., 2013 |
LMW- and HMW-SLPs | Alum | Intraperitoneal | Days 0, 21, 42 | Hamster | No significant protection | Ni Eidhin et al., 2008 |
SlpA precursor | Cholera toxin | Rectal | Days 0, 15, 30 | Mouse and hamster | Significant decrease of intestinal colonization at day 10 after challenge in mice. Partial but not lasting protection in hamsters | Bruxelle et al., 2016 |
Cwp84 | Cholera toxin | Rectal | Days 0, 15, 31 | Hamster | Significant increased survival (33%). Absence of colonization in surviving hamsters | Péchiné et al., 2011 |
Cwp84 | Pectin beads | Oral | Days 0, 15, 32 | Hamster | Forty percent of protection | Sandolo et al., 2011 |
FliC | Alum | Intraperitoneal | Days 0, 14, 28 | Mouse and hamster | Eighty nine percent of protection in mice 43 to 64% of protection in a dose dependent manner in hamsters | Ghose et al., 2016b |
GroEL | Cholera toxin | Nasal | Days 0, 7, 14, 28 | Mouse | Significant decrease of intestinal colonization | Péchiné et al., 2013 |
LTA-CRM197 | Alum | Subcutaneous | Days 0, 15, 30 | Mouse | Significant decrease of intestinal colonization | Broecker et al., 2016 |
Pilin | Freund’s adjuvant | Subcutaneous | Three immunizations | Mouse | Low antibody response. No protection | Maldarelli et al., 2016 |